Skip to main content
OpenTrials
Completed

NCT Number: NCT04769752

Beta Blocker Use in Cardiac Surgery and Association With Postoperative Course

The objective of this study is to describe in a cohort of cardiac surgery patients the use of beta-blockers before surgery and their maintenance or withdraw according to international recommendations in order to compare patients who receive a beta-blocker with maintenance during the surgical period (international recommendation) to those for whom prescription and maintenance are not respected. Patients are treated according to standard practice and this protocol does not change patient management. No additional information or data is required by the study other than the data usually collected in the patient record (drug treatment, medical history, operating data, postoperative data, complications, length of stay).

The objectives of this research are :

* To evaluate the proportion of patients receiving beta-blocker treatment prior to cardiac surgery. * To evaluate the proportion of patients receiving beta-blocker treatment before cardiac surgery and complying with international recommendations for its maintenance/stop in perioperative cardiac surgery. * To evaluate the incidence of complications and length of hospital stay in patients receiving beta-blockers based on compliance or non-compliance with recommendations.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Dijon Bourogne

Dijon, 21000, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Major patient ≥ 18 years
  • Patient operated cardiac surgery with cardiopulmonary bypass
  • Patients who have given oral consent to participate after full information

Exclusion criteria

  • Off pump cardiac surgery

Treatment and study plan

collection of the allocated treatment

Other

collection of the allocated treatment

collection of medical complications

Other

collection of medical complications

Primary outcomes

  1. Number of patients treated with beta-blocker in accordance with international guidelines

    Time frame: 7 days

    Number of patients treated with beta-blocker in accordance with international guidelines

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire Dijon

Other

Registry information

Official study title

Use and Prescription of Beta-blockers Before Cardiac Surgery With Cardiopulmopnary Bypass: Multicenter Observational Analysis of Practices and Its Association With Postoperative Morbidity-mortality.

Acronym: BLOCK

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Feb 24, 2021
Registry last updated
Feb 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.